Article Text

Download PDFPDF

Myocardial energetics and redox in health and disease
011 A new molecular mechanism for familial dilated cardiomyopathy based on studies with intact mutant transgenic mouse and human explanted heart muscle
  1. M Memo
  1. Imperial College, London, UK

Statistics from

We created a transgenic mouse that expressed the dilated cardiomyopathy (DCM) mutation ACTC E361G at 50% of total cardiac actin. We isolated F-actin from transgenic and non-transgenic (NTG) mice and reconstituted thin filaments using native human cardiac troponin and tropomyosin (from donor heart). In in-vitro motility assays we could observe no differences between E361G and non-transgenic mouse thin filaments; however, when troponin was fully dephosphorylated with acid phosphatase we observed that E361G Ca2+ sensitivity was lower than non-transgenic, as previously observed with the recombinant proteins (EC50 E361G/NTG 2.2±0.1). When we compared natively phosphorylated and dephosphorylated thin filaments we observed that Ca2+ sensitivity did not change in E361G mouse thin filaments (EC50 P/unP=1.0±0.1) but the Ca2+ sensitivity increased 3.0±0.3-fold on dephosphorylation of non-transgenic mice as expected. Thus the only functional change induced by the E361G mutation in cardiac actin was a blunted response to troponin I phosphorylation. We also studied troponin extracted from the explanted heart of a DCM patient carrying the cardiac TnC G159D mutation. In-vitro motility assay investigation of reconstituted thin filaments showed that the cTnC G159D mutation also showed little change in Ca2+ sensitivity when TnI was dephosphorylated (EC50 P/unP=1.2±0.2). In contrast, with donor heart control troponin, Ca2+ sensitivity was increased (EC50 P/unP=4.7±1.9). We conclude that Ca2+ sensitivity per se is not the prime determinant of familial DCM. The causative property shared by mutations in contractile proteins that cause DCM is a blunted response to changes in troponin I phosphorylation that could impair the normal response to adrenergic stimulation.

View Abstract


  • Funding This research was supported by grants from the British Heart Foundation

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.